WO2019083319A3 - 본 빌리브란트 인자(vwf)의 함량 조절이 가능한 제8인자 및 본 빌리브란트 인자를 포함하는 조성물의 제조방법 - Google Patents
본 빌리브란트 인자(vwf)의 함량 조절이 가능한 제8인자 및 본 빌리브란트 인자를 포함하는 조성물의 제조방법 Download PDFInfo
- Publication number
- WO2019083319A3 WO2019083319A3 PCT/KR2018/012820 KR2018012820W WO2019083319A3 WO 2019083319 A3 WO2019083319 A3 WO 2019083319A3 KR 2018012820 W KR2018012820 W KR 2018012820W WO 2019083319 A3 WO2019083319 A3 WO 2019083319A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- factor
- von willebrand
- vwf
- willebrand factor
- fviii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
- A61K38/37—Factors VIII
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/18—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
- B01D15/1864—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
- B01D15/1871—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in series
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
- B01D15/24—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the treatment of the fractions to be distributed
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/363—Anion-exchange
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA3079956A CA3079956C (en) | 2017-10-27 | 2018-10-26 | Method for preparing composition containing factor 8 capable of controlling content of von willebrand factor (vwf) and von willebrand factor |
CN201880075786.XA CN111491949B (zh) | 2017-10-27 | 2018-10-26 | 用于制备具有血管性血友病因子(vwf)受控含量的含有因子viii(fviii)和血管性血友病因子的组合物的方法 |
US16/758,386 US11608358B2 (en) | 2017-10-27 | 2018-10-26 | Method of preparing composition containing factor VIII (FVIII) and von Willebrand factor (vWF) with controlled content of von Willebrand factor (vWF) |
EP18870991.9A EP3719034A4 (en) | 2017-10-27 | 2018-10-26 | PROCESS FOR PREPARING A COMPOSITION CONTAINING A FACTOR 8 CAPABLE OF CONTROLLING THE CONTENT OF VON WILLEBRAND FACTOR (VWF) AND VON WILLEBRAND FACTOR |
KR1020207013083A KR102388176B1 (ko) | 2017-10-27 | 2018-10-26 | 본 빌리브란트 인자(vWF)의 함량 조절이 가능한 제8인자 및 본 빌리브란트 인자를 포함하는 조성물의 제조방법 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170141444 | 2017-10-27 | ||
KR10-2017-0141444 | 2017-10-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019083319A2 WO2019083319A2 (ko) | 2019-05-02 |
WO2019083319A3 true WO2019083319A3 (ko) | 2019-06-20 |
Family
ID=66247284
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/012820 WO2019083319A2 (ko) | 2017-10-27 | 2018-10-26 | 본 빌리브란트 인자(vwf)의 함량 조절이 가능한 제8인자 및 본 빌리브란트 인자를 포함하는 조성물의 제조방법 |
Country Status (6)
Country | Link |
---|---|
US (1) | US11608358B2 (ko) |
EP (1) | EP3719034A4 (ko) |
KR (1) | KR102388176B1 (ko) |
CN (1) | CN111491949B (ko) |
CA (1) | CA3079956C (ko) |
WO (1) | WO2019083319A2 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11155310B2 (en) * | 2019-10-07 | 2021-10-26 | Honda Motor Co., Ltd. | Asymmetrical tailgate |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0934748B1 (en) * | 1997-12-15 | 2005-10-19 | HemaSure Denmark A/S | Von Willenbrand factor (vWF)- containing preparation, process for preparing vWF-containing preparations, and use of such preparations |
KR20100058520A (ko) * | 2007-08-30 | 2010-06-03 | 엘에프비 바이오테크놀로지스 | 인자 Ⅷ 및 폰 빌리브란트 인자(vWF)의 정제 방법 |
WO2010082184A1 (en) * | 2009-01-19 | 2010-07-22 | Kedrion S.P.A. | New process for highly selective purification of two plasma proteins: von willebrand factor (vwf) and fibronectin (fn) |
WO2015021423A2 (en) * | 2013-08-08 | 2015-02-12 | Biogen Idec Ma Inc. | Purification of chimeric fviii molecules |
WO2016162310A1 (en) * | 2015-04-10 | 2016-10-13 | Ge Healthcare Bioprocess R&D Ab | Method for chromatography |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4361509A (en) | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
US4764369A (en) | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
IT1256622B (it) * | 1992-12-04 | 1995-12-12 | Sclavo Spa | Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale. |
JP3820307B2 (ja) | 1997-10-23 | 2006-09-13 | 保芦 将人 | 逆転写酵素阻害剤 |
CN105622746A (zh) * | 2016-02-04 | 2016-06-01 | 江西博雅生物制药股份有限公司 | 一种从冷沉淀提取凝血因子ⅷ的废料中提取人血管性血友病因子的制备工艺 |
-
2018
- 2018-10-26 CN CN201880075786.XA patent/CN111491949B/zh active Active
- 2018-10-26 EP EP18870991.9A patent/EP3719034A4/en active Pending
- 2018-10-26 WO PCT/KR2018/012820 patent/WO2019083319A2/ko unknown
- 2018-10-26 CA CA3079956A patent/CA3079956C/en active Active
- 2018-10-26 KR KR1020207013083A patent/KR102388176B1/ko active IP Right Grant
- 2018-10-26 US US16/758,386 patent/US11608358B2/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0934748B1 (en) * | 1997-12-15 | 2005-10-19 | HemaSure Denmark A/S | Von Willenbrand factor (vWF)- containing preparation, process for preparing vWF-containing preparations, and use of such preparations |
KR20100058520A (ko) * | 2007-08-30 | 2010-06-03 | 엘에프비 바이오테크놀로지스 | 인자 Ⅷ 및 폰 빌리브란트 인자(vWF)의 정제 방법 |
WO2010082184A1 (en) * | 2009-01-19 | 2010-07-22 | Kedrion S.P.A. | New process for highly selective purification of two plasma proteins: von willebrand factor (vwf) and fibronectin (fn) |
WO2015021423A2 (en) * | 2013-08-08 | 2015-02-12 | Biogen Idec Ma Inc. | Purification of chimeric fviii molecules |
WO2016162310A1 (en) * | 2015-04-10 | 2016-10-13 | Ge Healthcare Bioprocess R&D Ab | Method for chromatography |
Also Published As
Publication number | Publication date |
---|---|
US20200247843A1 (en) | 2020-08-06 |
KR20200060504A (ko) | 2020-05-29 |
CN111491949B (zh) | 2024-01-09 |
EP3719034A4 (en) | 2021-07-28 |
KR102388176B1 (ko) | 2022-04-19 |
US11608358B2 (en) | 2023-03-21 |
CA3079956A1 (en) | 2019-05-02 |
EP3719034A2 (en) | 2020-10-07 |
CA3079956C (en) | 2023-06-27 |
WO2019083319A2 (ko) | 2019-05-02 |
CN111491949A (zh) | 2020-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2017031476A3 (en) | Purification of fkpa and uses thereof for producing recombinant polypeptides | |
MX353515B (es) | Metodo para producir clinker de ternesita-belita-sulfoanuminato de calcio. | |
MX2019015932A (es) | Metodo para producir un edulcorante de alulosa. | |
UA102843C2 (uk) | Спосіб виробництва щонайменше однієї сполуки-похідної етилену | |
SG11201906688VA (en) | Novel ester compounds, method for the production thereof and use thereof | |
MX2007010141A (es) | Procesos para la preparacion de intermedios de linezolid. | |
PH12014501232A1 (en) | Palm-based oil and method for producing same | |
MX2021011401A (es) | Metodo para la deteccion y cuantificacion de fosfomicina y de sus impurezas y/o productos de degradacion. | |
WO2019083319A3 (ko) | 본 빌리브란트 인자(vwf)의 함량 조절이 가능한 제8인자 및 본 빌리브란트 인자를 포함하는 조성물의 제조방법 | |
WO2019234614A3 (en) | A process for the separation and purification of phycobiliproteins | |
EA200801328A1 (ru) | Промышленный способ получения высокочистого диарилкарбоната | |
MX2022008276A (es) | Metodo para purificar sulfoxido de dimetilo. | |
SG136934A1 (en) | Process for separating zirconium and hafnium | |
MX2021015300A (es) | Métodos de producción de un anticuerpo anti-¿4¿7. | |
MX2016012851A (es) | Un metodo para producir 1,1,2,3-tetracloropropeno con alto rendimiento. | |
MX2022007679A (es) | Composiciones purificadas de enterovirus y metodos de purificacion por cromatografia de afinidad con glutation. | |
MX2016002870A (es) | Moleculas que contienen fc que presentan perfiles de glicoforma predecibles, consistentes y reproducibles. | |
NZ707753A (en) | Purification of recombinant human galactocerebroside β-galactosidase (rhgalc) | |
MY183686A (en) | Processes for purifying acetic acid and hydrating anhydride | |
MX2016005264A (es) | Procedimiento para purificar darbepoyetina alfa. | |
WO2019060475A3 (en) | SYNTHESIS OF ORGANO-CHLOROSILANES FROM ORGANOSILANES | |
MX2022015388A (es) | Procedimiento para la purificación de una mezcla de dioles. | |
MY180951A (en) | Process and apparatus for purification of acrylic acid | |
CA3150530A1 (en) | CANNABICHROMENE COMPOSITIONS AND METHODS FOR SYNTHESIZING CANNABICHROMENE | |
MY190816A (en) | A process for purifying methyl ester sulphonate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 3079956 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 20207013083 Country of ref document: KR Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2018870991 Country of ref document: EP Effective date: 20200527 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18870991 Country of ref document: EP Kind code of ref document: A2 |